Hauser SL, et al. Efficacy and safety of ofatumumab versus teriflunomide in relapsing multiple sclerosis: results of the phase 3 ASCLEPIOS I and II trials. Abstract 336. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Nederlandse Hersenbank: doodsoorzaak te vaak onjuist
apr 2017 | Bewegingsstoornissen, Dementie, Multipele Sclerose